BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37028977)

  • 21. External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome.
    Zhao Z; Wickersham N; Kangelaris KN; May AK; Bernard GR; Matthay MA; Calfee CS; Koyama T; Ware LB
    Intensive Care Med; 2017 Aug; 43(8):1123-1131. PubMed ID: 28593401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validating Measures of Disease Severity in Acute Respiratory Distress Syndrome.
    Sedhai YR; Yuan M; Ketcham SW; Co I; Claar DD; McSparron JI; Prescott HC; Sjoding MW
    Ann Am Thorac Soc; 2021 Jul; 18(7):1211-1218. PubMed ID: 33347379
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-term mortality prediction for acute lung injury patients: external validation of the Acute Respiratory Distress Syndrome Network prediction model.
    Damluji A; Colantuoni E; Mendez-Tellez PA; Sevransky JE; Fan E; Shanholtz C; Wojnar M; Pronovost PJ; Needham DM
    Crit Care Med; 2011 May; 39(5):1023-8. PubMed ID: 21761595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Ventilator-associated Pneumonia Prediction Model in Patients With Acute Respiratory Distress Syndrome.
    Wu Z; Liu Y; Xu J; Xie J; Zhang S; Huang L; Huang Y; Yang Y; Qiu H
    Clin Infect Dis; 2020 Dec; 71(Suppl 4):S400-S408. PubMed ID: 33367575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of combination of lung injury prediction score and receptor for advanced glycation end‑products for the occurrence of acute respiratory distress syndrome.
    Yang J; Wei A; Wu B; Deng J
    Exp Ther Med; 2024 Jan; 27(1):4. PubMed ID: 38223323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning.
    Xu W; Sun NN; Gao HN; Chen ZY; Yang Y; Ju B; Tang LL
    Sci Rep; 2021 Feb; 11(1):2933. PubMed ID: 33536460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Acute Respiratory Distress Syndrome in Traumatic Brain Injury Patients Based on Machine Learning Algorithms.
    Wang R; Cai L; Zhang J; He M; Xu J
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676795
    [No Abstract]   [Full Text] [Related]  

  • 30. Lung Injury Prediction Model in Bone Marrow Transplantation: A Multicenter Cohort Study.
    Herasevich S; Schulte PJ; Hogan WJ; Alkhateeb H; Zhang Z; White BA; Khera N; Roy V; Gajic O; Yadav H
    Am J Respir Crit Care Med; 2024 Mar; 209(5):543-552. PubMed ID: 38051944
    [No Abstract]   [Full Text] [Related]  

  • 31. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep Learning With Chest Radiographs for Making Prognoses in Patients With COVID-19: Retrospective Cohort Study.
    Lee HW; Yang HJ; Kim H; Kim UH; Kim DH; Yoon SH; Ham SY; Nam BD; Chae KJ; Lee D; Yoo JY; Bak SH; Kim JY; Kim JH; Kim KB; Jung JI; Lim JK; Lee JE; Chung MJ; Lee YK; Kim YS; Lee SM; Kwon W; Park CM; Kim YH; Jeong YJ; Jin KN; Goo JM
    J Med Internet Res; 2023 Feb; 25():e42717. PubMed ID: 36795468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of transcriptional biomarkers and clinical parameters for early prediction of sepsis indued acute respiratory distress syndrome.
    Yao RQ; Shen Z; Ma QM; Ling P; Wei CR; Zheng LY; Duan Y; Li W; Zhu F; Sun Y; Wu GS
    Front Immunol; 2022; 13():1084568. PubMed ID: 36685531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prediction model for acute respiratory distress syndrome among patients with severe acute pancreatitis: a retrospective analysis.
    Lin F; Lu R; Han D; Fan Y; Zhang Y; Pan P
    Ther Adv Respir Dis; 2022; 16():17534666221122592. PubMed ID: 36065909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
    Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R;
    JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic value of mechanical power in patients with moderate to severe acute respiratory distress syndrome: an analysis using the data from MIMIC-III].
    Yan Y; Xie Y; Wang Y; Chen X; Sun Y; Du Z; Li X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):35-40. PubMed ID: 35307058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a clinical risk model to predict the hospital mortality in ventilated patients with acute respiratory distress syndrome: a population-based study.
    Ye W; Li R; Liang H; Huang Y; Xu Y; Li Y; Ou L; Mao P; Liu X; Li Y
    BMC Pulm Med; 2022 Jul; 22(1):268. PubMed ID: 35820835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dynamic measurement of volume of atelectasis area in the evaluation of the prognosis of patients with moderate-to-severe acute respiratory distress syndrome].
    Lu X; Han Y; Gao X; Wang F; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1056-1060. PubMed ID: 33081890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
    COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
    Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome.
    Bos LD; Schouten LR; Cremer OL; Ong DSY; Schultz MJ;
    Ann Intensive Care; 2016 Dec; 6(1):89. PubMed ID: 27638132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.